trending Market Intelligence /marketintelligence/en/news-insights/trending/3MDOrXzfpKtpVME_UdlWJA2 content esgSubNav
In This List

Suda raises A$1.5M in underwritten placement

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Suda raises A$1.5M in underwritten placement

Suda Ltd. raised A$1.5 million in an oversubscribed underwritten placement of 75 million fully paid ordinary shares at 2 Australian cents apiece.

The company will use the funds to commercialize and further develop its drug pipeline, which includes ZolpiMist for the treatment of insomnia.

RM Corporate Finance acted as the lead manager and underwriter of the placement.

As of April 6, US$1 was equivalent to A$1.32.